NEW: Life Sciences Partnership of the Year

newthis
NEW: Life Sciences Partnership of the Year
Read more

How to apply

  1. Register an account.
  2. Start your entry (save it in-progress).
  3. Submit your entry to be in the running.

Best of luck!

Start your entry

The Life Sciences Sector Plan and the 10 Year Health Plan place life sciences at the heart of NHS reform, with the ambition to make the UK a world leader in genomics, diagnostics and precision medicine and to get proven innovations to patients faster. Genomics, diagnostics and the data that underpins them are moving especially fast, and the NHS is building the infrastructure, regional networks and partnerships needed to translate science into care.

Delivering this safely depends on partnerships that work effectively across organisational boundaries and take a careful, transparent approach to data, one that maintains the confidence of patients, clinicians and the public. Regional genomic medicine services, research collaborations and industry partners all have a role to play. 

This award recognises a partnership between a life sciences company and one or more NHS bodies where the company has provided a diagnostic, device, test, genomic service, or body of evidence that has advanced research, innovation or care for NHS patients. It is intended for diagnostics, medical device, genomics, biotech and data or real-world evidence partners, where the deliverable exists independently of any single medicine. Partnerships centred on a specific drug, prescribing optimisation or medicines access should enter Best Pharmaceutical Partnership with the NHS. Judges will be looking for genuine partnership working, a robust approach to data and governance, and tangible benefits for patients and the wider system.

Eligibility

  • Open to diagnostics, medical device, genomics, biotech, and data or real-world evidence companies, and other life sciences partners working with one or more NHS organisations, where the partnership delivers a test, device, diagnostic or genomic capability, or body of evidence.
  • This award is not for partnerships centred on a specific medicine, prescribing optimisation or medicines access; those should enter Best Pharmaceutical Partnership with the NHS.
  • Entries must demonstrate a collaborative approach to research, innovation or care that benefits NHS patients, with a clear and well-governed approach to data.
  • Evidence must relate to work delivered within the past two years up until the awards entry deadline.

Ambition

The challenge and context within which your project, person or organisation is set alongside your goals and targets whether quantitative or qualitative, and how this aligns with national priorities.

  • Describe the research, diagnostic, genomic or evidence challenge the partnership addressed, and the capability the company brought to it.
  • Explain how the work aligns with the Life Sciences Sector Plan and the NHS's ambitions for genomics, diagnostics and precision medicine.
  • Set out the goals agreed and how success was defined.

Collaboration

The stakeholders’ involvement in co-designing and delivering the project. How have patients, staff at all levels, communities and other parties worked together to realise the outcomes?

  • Describe how partners worked effectively across organisational boundaries, including regional networks where relevant.
  • Explain the approach taken to data and governance and how it maintained the confidence of patients, clinicians and the public.
  • Provide evidence of genuine partnership and shared ownership.

Impact

The measurable benefits delivered to patients, staff, your organisation or the wider system. Provide data and evidence showing improvements to outcomes, quality, access, equity or efficiency.

  • Provide measurable evidence of benefit for NHS patients, such as earlier or more accurate diagnosis, expanded testing capacity or improved outcomes.
  • Share data and feedback demonstrating real-world impact.
  • Demonstrate value to the wider system and to research.

Scale

How your work has been shared, adopted or replicated beyond your immediate team or organisation. This includes dissemination through publications, presentations, toolkits, partnerships or inspiring similar initiatives elsewhere.

  • Explain how the test, device, genomic service or evidence base has been replicated or adopted more widely.
  • Describe contributions to system-wide learning and best practice.

Sustainability

The potential for the project/work to continue and create lasting impact. Evidence of how it can be sustained or built upon.

  • Describe how the partnership and its benefits can be sustained over the long term.
  • Explain how it supports continued research, innovation and access.

NEW: Life Sciences Partnership of the Year

Start your entry

To find out more

Partnership opportunities:  Sponsorship Sales Team
Awards entry enquiries: Support Team
Judging and event management: Awards Support